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Abstract
The high incidence of aneurysms of different arterial systems in case of abdominal aortic aneurysm causes the need for
the examination of all patients with aortic aneurysm in order to detect aneurysmal process in all main arteries. The use of
the mentioned predictors of aneurism wall failure in daily clinical practice provides an opportunity to improve the results of
surgical treatment. Active surgical approach in relation to aortic aneurysm and main arteries is indicated in the presence
of aneurismal disease. The choice of treatment depends on the severity of the patient’s condition, clinical manifestations,
localization of the aneurysm and its morphology, with the preference for endovascular approach.
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Discussion
Aortic aneurysms are a permanent, limited dilation of the ves-
sel exceeding their normal sizes by 50% or more, are fraught
with the development of various dangerous complications
(dissection, rupture, thrombosis, thrombembolia). The inci-
dence of aortic aneurysm (A) among the vascular diseases
constitutes 3.4-6.7% and tends to further increase [4, 5]. The
increase in the number of aneurysmal disease (AD) of various
arterial systems begins with the increase in the number of
cardiovascular diseases, improved diagnostic methods as well
as increase in vascular traumatization (motor vehicle acci-
dents, home traumatism, violent conflicts, iatrogenic injuries,
diagnostic and therapeutic endovascular interventions) [17].
According to A.V. Pokrovskyi, the detection frequency
of different arterial systems A in case of abdominal aortic
aneurysm reaches 33.9% [14]. According to Yu.V. Cherviakov
and co-authors, for the period from 1993 to 2009 51 patients
(20.5%) suffered from AD of aortic and other major arteries
branches among treated 248 patients with abdominal aortic
aneurysm and thoracoabdominal aortic aneurysm [16]. These
data indicate the similarity of the pathological processes in
the aorta and main arteries of different locations.
The Ebers Papyrus written about 2000 years ago BC does
not provide any information on arterial A description, but
there are recommendations for their elimination. “It should
be treated with a knife and burned with fire so that the hem-
orrhage is small”. The first mention of splanchnic arteries
aneurysms (SAA) in the medical literature refers to 1770.
More than 3500 cases of SAA have been reported since that
time [15].
Arterial wall damage in AD is often of generalized na-
ture and has progressive course. Such type of vascular wall
damage is called aneurysm [16].
Common cause for arterial aneurysms development is
trauma, followed by atherosclerosis. Postoperative and dys-
plastic A are less common. Infectious (mycotic) aneurysm
is even rarer. Arterial A development in women is caused by
fibromuscular dysplasia.
Causes of SAA development include atherosclerosis, fibro-
muscular dysplasia, collagen fibers dysmorphology, reduction
of muscle fibers, trauma, infection, inflammation, vasculitis
[24].
Frequent symptoms of arterial A are the presence of pulsat-
ing formation, rarely pain in the area of arterial A and chronic
limb ischemia (35-44%). Acute ischemia of tissue is observed
in 11% of cases. Asymptomatic A are detected in 6% of
cases [11]. Clinical manifestations of profunda femoris artery
A growth are absent. Clinical picture appears only when A
becomes large in size manifesting in a subjective pulsation
feeling in the thigh, numbness of thigh medial surface due
to nerve compression and swelling of the lower limbs due to
venous compression which in some cases is complicated by
deep vein thrombosis [6, 27, 30].
Bilateral A lesion of popliteal artery is ascertain 47-63%
of cases [9]. Clear prognostic criteria of A growth, violations
of its wall integrity and prevention of aneurysmal lesions of
other arterial systems are not observed [4]. Splenic artery
aneurysms are the most frequent among SAA; hepatic artery
aneurysms rank the second place; aneurysms of gastroduode-
nal arteries, pancreaticoduodenal arteries and pancreatic ar-
teries are less common; superior mesenteric artery and celiac
trunk arteries aneurysms are even rarer [15, 24, 35].
The range of clinical manifestations is limited and nonspe-
cific. Patients complain of abdominal pain of different local-
ization and nature, abdominal discomfort. Abdominal cavity
organs diseases (acute and chronic pancreatitis, cholelithiasis,
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tumors, etc.) have been previously diagnosed in these patients
[18, 34].
False aneurysms (FA) are very common complications
associated with implantation of a synthetic prosthetic de-
vice. One of the main primary factors of anastomotic false
aneurysms development is degenerative changes of the arterial
wall due to the progression of the underlying disease. Infec-
tious complications are believed to be the most important in
the occurrence of early FA [2]. Other authors consider the
use of synthetic materials to cause FA. Different extensibil-
ity degree of prosthetic device and artery in the area of the
anastomosis may lead to the cutting of the artery wall with
subsequent FA development. The value of hydrodynamic
impact in anastomosis area and the effect of arterial hyper-
tension and high peripheral resistance to the possibility of FA
development are analyzed in the literature [13]. Technical
aspects of the surgery (not deep injection into the vascular
wall, overexertion during anastomotic sutures putting) are also
of certain value [13].
The frequency of FA formation in the area of vascular
anastomosis reaches 20% and has no tendency to decrease
and mortality ranges from 5.8 to 17.2% in repeated operations
[5, 13].
The opportunity to determine topographic and anatomic
features of the process with great objectivity, to study the struc-
tural changes in A wall has appeared due to the widespread
practical application of contrast-enhanced multispiral com-
puted tomography.
The approach to the solution of the issue concerning ab-
dominal aortic aneurysm (over 7 cm) is rather clear, however,
the solution of the issue regarding smaller A is ambiguous.
Earlier accepted approach has not proved its value. It con-
sists in determination of the growth dynamics and surgery
performance in case of an increase in the maximum transverse
size over 6 mm per year. According to the statistics results
the rupture of aortic A up to 5 cm was noted in 5-7% of pa-
tients and with the size of 5-6 cm in 15-18% of patients per
year. Moreover, quickly progressing A growth (> 6 mm) was
observed only in 3-4% of patients [17, 23].
Having assessed the factors affecting the risk of rupture
of abdominal aortic aneurysm, in 2003 D.C. Brewster and
co-authors grouped them and classified into low, medium
and high risk levels. They advised to adhere to this classifi-
cation in choosing the approach of such patients’ treatment
[19]. According to A. A. Nikonenko and co-authors, the
volume of internal aneurismal thrombotic masses as a mor-
phological criterion, namely the predictor of rupture of small
size A aorta is leading in pathogenesis. Internal aneurismal
thrombotic masses have been clinically proven to have a high
proteolytic activity towards extracellular stromal structures of
the intima-media and are directly proportional to the risk of A
dissection or rupture. However, specific quantitative indica-
tors of metabolic proteolysis in AD as an element of control
and factor for the prognosis of process development have not
been identified up to this day. Nevertheless, according to A. A.
Nikonenko and co-authors, intraluminal thrombotic masses
were the criterion for small A ruptures in 10% of cases [12].
A number of researchers indicate correlation between the
frequency of A ruptures and the severity of the systemic in-
flammatory response [8, 9, 25]. Raffetto and colleagues have
noted an increase in the concentration of interleukin (IL) 1 and
6 in plasma by 1.5 times 24 hours before the actual A rupture
[31]. Rozavian and co-authors have noted that the highest
indices of IL-6 and tumor necrosis factor α are observed in
1-2 days after the surgery for abdominal aorta prosthesis with
subsequent stabilization of their levels during 5-7 days [32].
One of the sensitive tests to determine the risk of A rup-
ture through quantitative analysis of macrophages proteolytic
activity is determination of the metabolic predictors concen-
tration in plasma, namely matrix metalloproteinases MMP-2
and MMP-9 [4, 31, 36].
Concerning the possible biochemical and histological
markers in the origin, development and progressing of AD of
different main arteries, A is histologically characterized by
destruction of elastin and collagen in media and adventitia
as well as the loss of smooth muscle cells with thinning of
the middle layer. In addition, wall infiltration by lymphocytes
and macrophages with neovascularity has been noted [8, 13].
The process is mainly localized in the intima and media in
case of atherosclerosis, whereas pathology affects media and
adventitia in case of A.
Combination of different factors such as local hemody-
namic overload, destruction of middle layer proteins, genetic
disposition play a specific pathogenetic role in AD occurrence
[8]. Such mechanisms of innate immunity as Toll-like recep-
tors are involved in the ways of atherogenesis initiation [1].
Activation of these receptors triggers different intracellular
pathways of signal transmission to the synthesis of proinflam-
matory cytokines. Intense activation of inflammation may be
an important risk factor for atherosclerosis [7, 22, 33]. The
release of active substances leads to an increased migration
of leukocytes into the aortic wall with the subsequent release
and activation of metalloproteinases. Proteinases, in their turn,
lead to degradation of the middle layer, aneurysmal dilatation
and hemodynamic vascular remodeling [25]. Hemodynamic
overload of aortic walls in A area enhances the proteolysis,
leads to dilatation progression and subsequent rupture [9].
Occurrence and progression of A is now decided to be
associated with four basic mechanisms, namely proteoclastic
degradation of arterial wall connective tissue, inflammation
and immune reactions in the wall, biochemical stress, and
molecular genetics [37].
Studies and observations of A results have showed that
the risk of its rupture is affected by obstructive lung disease,
smoking, hypertension and heredity in addition to A diameter,
shape, rate, volume increase [8, 19].
Taking into account the high risk of A rupture, treatment
of symptomatic and asymptomatic arterial aneurysm along
with fatal bleeding is necessary. Treatment choice depends
on the patient, clinical symptoms, and its localization and
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Table 1. The risk of abdominal aortic aneurysm ruptures according to D.C. Brewster
Risk factors Risk levelLow Medium High
Diameter of abdominal aortic aneurysm <5 cm 5-6 cm >6 cm
Aneurysm growth rate <0.3 cm/year 0.3-0.6 cm/year >0.6 cm/year
Smoking / COPD No Moderately severe Severe/ steroids
Family history No relatives One relative Many relaives
Hypertension no Controlled Poorly controlled
Form Fusiform Sacciform Accentric
Wall stress low (35 N/cm) Medium (40 N/cm) High (45 N/cm)
Sex - Male Female
morphology.
Five-year survival of patients with abdominal aortic aneurysm
without surgery constitutes 18% and in operated patients this
figure is 90-60%. A are often located in the abdominal aorta
and iliac arteries, rarely in the femoral and popliteal ones.
Posterior tibial artery and brachial artery are less affected.
Yu.V. Cherviakov and colleagues treated 39 (15.8%) pa-
tients with iliac arteries aneurysm (one third of them was
with bilateral lesions), 37 (14.9%) patients with aneurismal
lesions of the femoral arteries (one third of them was also with
bilateral lesions), and 14 (5.2%) patients with lesion of the
popliteal-tibial segment among 248 patients with abdominal
aortic aneurysm and thoracoabdominal aortic aneurysm [16].
Aortography of two patients with multiple bilateral aneurys-
mal lesions of the aorta, iliac, femoral and popliteal arteries
who were observed in 2015-2016 is provided below. Among
471 patients operated at the Scientific Center of Cardiovascu-
lar Surgery, linear aortic prosthesis concerning A lesions was
conducted in 198 (42%) patients, aortoiliac prosthesis was
performed in 165 (35%) patients, aorto-femoral bifurcation
prosthesis was applied in 108 (22.9%) patients [3]. The great-
est number of complications and symptomatic manifestation
of abdominal aortic aneurysm was observed in the group of
patients with aneurysms more than 7 cm in size [3].
Resection with the affected artery replacement is usually
performed. Resection of A with pleural suture of the artery
and by-pass technique is applied rarely. Resection of A with
arterio-arterial end-to-end anastomosis or end-to-side anasto-
mosis as well as lateral patchplasty after A resection are used
more rarely. Extraanatomic bypass is conducted in case of
infectious (mycotic) aneurysm [5, 6].
However, the surgical treatment of aortic aneurysm has
a number of disadvantages such as high surgical injury rate,
high postoperative mortality reaching 3 to 12.5 %. In addition,
a wide range of comorbidities among older people limits the
possibility of open surgical treatment. Thus, the mortality rate
among patients operated on for abdominal aortic aneurysm
constitutes 4% in patients under 55 and increases to 10%
among patients older than 75 [20].
The average in-patient mortality constitutes 3.8-9.2% in
case of abdominal aortic aneurysm resection and 1-2% in
endoprosthesis replacement. Endovascular technologies of
aortic aneurysm and main arteries aneurysm have developed
from application of linear endoprostheses to the creation of
bifurcation aorto-femoral stent-graft [20, 26].
Endoprosthesis replacement provides an opportunity to
avoid fatal outcomes in severe patients with aortic aneurysm
and main arteries aneurysm. Endovascular interventions in-
clude removal of aortic or main artery A from blood flow,
embolization of A cavity, artery embolization distal and prox-
imal to aneurysmal neck, endoprosthesis replacement, stent-
assisted occlusion [21].
Naganuma M. and co-authors reported about successful
treatment of 534 patients with splenic artery A treated at 229
hospitals in Japan. The patients underwent transcatheter A em-
bolization. Early postoperative complications were observed
in 6% of cases [29].
Melissano G. and co-authors successfully treated 26 pa-
tients with hepatic artery A in size from 2 to 17 cm. 17
patients underwent open surgery and 9 patients underwent
endovascular treatment (5 of them underwent platinum coil
embolization of aneurysm, and stent-graft was performed to 4
patients) [28].
Thus, a high detection rate of aneurysms of different arte-
rial systems in case of abdominal aortic aneurysm causes the
need for the examination of all patients with aortic aneurysm
in order to detect aneurysmal process in other main arteries.
Active surgical approach in relation to aortic aneurysm and
main arteries is indicated in the presence of aneurismal dis-
ease. The choice of treatment depends on the severity of
the patient’s condition, clinical manifestations, localization
of the aneurysm and its morphology, with the preference for
endovascular approach. The use of the mentioned predictors
of aneurism wall failure in daily clinical practice provides an
opportunity to improve the results of surgical treatment.
Summarizing the facts presented above, it can be noted
that more and more new data on aneurysm growth and its
wall integrity violation constantly emerge. This provides
new opportunities to reconsider the diagnosis and surgical
treatment of aneurysmal disease of the main arteries.
Clear pathogenesis of A lesions of various arterial sys-
tems providing the opportunity to ensure pathogenetically
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Figure 1. The patient Ivaskiv Yosyp Volodymyrovch, 1936 year of birth (case history #1943615).
based drug correction and prevention of AD have not been
determined so far.
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Figure 2. The patient Syvukhin Ihor Mykhailovych, 1957 year of birth.
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